Great Point Partners as of Sept. 30, 2020
Portfolio Holdings for Great Point Partners
Great Point Partners holds 33 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 11.5 | $128M | 3.9M | 32.92 | |
| Sage Therapeutics (SAGE) | 10.8 | $120M | 2.0M | 61.12 | |
| ACADIA Pharmaceuticals (ACAD) | 7.1 | $79M | 1.9M | 41.25 | |
| Arena Pharmaceuticals Com New | 6.7 | $75M | 997k | 74.79 | |
| Zymeworks | 6.6 | $73M | 1.6M | 46.58 | |
| United Therapeutics Corporation (UTHR) | 5.8 | $65M | 641k | 101.00 | |
| Cytokinetics Com New Put Option (CYTK) | 5.5 | $61M | 2.8M | 21.65 | |
| Constellation Pharmceticls I | 5.2 | $58M | 2.9M | 20.26 | |
| Gw Pharmaceuticals Ads | 4.6 | $51M | 520k | 97.35 | |
| Tg Therapeutics (TGTX) | 3.9 | $43M | 1.6M | 26.76 | |
| Macrogenics (MGNX) | 3.4 | $38M | 1.5M | 25.19 | |
| Aurinia Pharmaceuticals (AUPH) | 3.3 | $37M | 2.5M | 14.73 | |
| Global Blood Therapeutics In | 3.3 | $36M | 656k | 55.14 | |
| Biohaven Pharmaceutical Holding | 2.5 | $28M | 435k | 65.01 | |
| Vericel (VCEL) | 2.5 | $27M | 1.5M | 18.53 | |
| Glaukos (GKOS) | 2.0 | $22M | 446k | 49.52 | |
| Geron Corporation (GERN) | 1.5 | $17M | 9.7M | 1.74 | |
| Prothena Corp SHS (PRTA) | 1.4 | $16M | 1.5M | 9.99 | |
| Sangamo Biosciences (SGMO) | 1.4 | $15M | 1.6M | 9.45 | |
| Chemocentryx | 1.2 | $14M | 253k | 54.80 | |
| Translate Bio | 1.2 | $13M | 943k | 13.61 | |
| Allogene Therapeutics (ALLO) | 1.1 | $12M | 329k | 37.71 | |
| Intersect Ent | 1.1 | $12M | 748k | 16.31 | |
| Inventiva Sa Ads (IVA) | 1.1 | $12M | 999k | 11.82 | |
| Puma Biotechnology (PBYI) | 1.0 | $11M | 1.1M | 10.09 | |
| Calithera Biosciences | 0.9 | $10M | 2.9M | 3.45 | |
| Kadmon Hldgs | 0.9 | $9.8M | 2.5M | 3.92 | |
| Viewray (VRAYQ) | 0.8 | $9.3M | 2.7M | 3.50 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $7.5M | 595k | 12.67 | |
| Liquidia Technologies (LQDA) | 0.5 | $5.9M | 1.2M | 4.92 | |
| Abeona Therapeutics | 0.4 | $4.0M | 3.9M | 1.02 | |
| Millendo Therapeutics | 0.2 | $1.9M | 1.2M | 1.63 | |
| Oyster Point Pharma | 0.1 | $1.5M | 70k | 21.11 |
